MIT Technology Review Research
7/23/2026

How AI helps scientists design the next generation of medicines
Short summary
AI is transforming drug discovery by helping scientists design biologic medicines more efficiently. Traditional drug development is expensive and failure-prone, with most candidates never reaching patients. AI tools can accelerate protein engineering and candidate screening, potentially reducing development timelines and costs for next-generation therapies.
- •AI accelerates biologic drug design by assisting with protein engineering
- •Traditional drug development is costly with high failure rates
- •AI could reduce timelines and investment needed for new medicines
Generated with AI, which can make mistakes.
Is this a good recommendation for you?



